Company: BIVIW
Filing Date: 2025-07-22
Form Type: S-1/A
Source: 0001520138-25-000216
Chunk: 226

Company: BIOVIE INC.
Filing Date: 2025-07-22
Form: S-1/A
Chunk 226
---
 dividends, stock splits, and reverse stock splits. Pursuant to the
terms of the Placement Agent III Warrants, the holders of the Placement Agent III Warrants are entitled to piggyback registration rights
if the Company proposes to file a new registration statement under the Securities Act, subject to certain limitations.

Private Placement II Warrants and Placement Agent IV Warrants Issued in Connection with Offering October 23, 2024

On October 23, 2024, the Company entered into
the October 23, 2024 PAA with ThinkEquity LLC, as the placement agent, in connection with the issuance and sale directly to the October
23 Investors of up to 266,700 shares of the Common Stock, at a public offering price to the October 23 Investors of $22.50 per share.

In a concurrent private placement, pursuant to
the October 23, 2024 PAA, the Company issued to the October 23 Investors unregistered Private Placement II Warrants to purchase 266,700
shares of Common Stock, with each Private Placement II Warrant exercisable for one share of Common Stock at an exercise price of $21.20
per share. Each Private Placement II Warrant will be exercisable beginning six months from the date of issuance and will expire five years
following the initial exercise date.

The holders of the Private Placement II Warrants
may exercise the Private Placement II Warrants by making a cash payment equal to the exercise price multiplied by the quantity of shares.
The holders of the Private Placement II Warrants may also exercise the Private Placement II Warrants on a cashless or “net issuance”
basis by receiving a net number of shares calculated pursuant to the formula set forth in the Private Placement II Warrants. The Private
Placement II Warrants are subject to anti-dilution adjustments for stock dividends, stock splits, and reverse stock splits. Pursuant to
the terms of the Private Placement II Warrants, the Company has the obligation to file a registration statement on Form S-1 providing
for the resale by the holders of the Private Placement II Warrants of the shares of Common Stock issued and issuable upon exercise of
the Private Placement II Warrants.

In connection with the October 23 Offering, the
Company issued the Placement Agent IV Warrants, exercisable to purchase 13,335 shares of Common Stock, representing 5% of the October
23 Shares purchased at the closing of the October 23 Offering, for an aggregate purchase price of $